Amedisys, Inc. (AMED)
USD 84.97
(-0.47%)
USD 84.97
(-0.47%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -9.74 Million USD | -108.22% |
| 2022 | 118.6 Million USD | -43.27% |
| 2021 | 209.07 Million USD | 13.87% |
| 2020 | 183.6 Million USD | 44.76% |
| 2019 | 126.83 Million USD | 6.27% |
| 2018 | 119.34 Million USD | 293.87% |
| 2017 | 30.3 Million USD | -18.68% |
| 2016 | 37.26 Million USD | 1333.4% |
| 2015 | -3.02 Million USD | -123.65% |
| 2014 | 12.77 Million USD | 113.28% |
| 2013 | -96.17 Million USD | -15.06% |
| 2012 | -83.58 Million USD | 78.14% |
| 2011 | -382.46 Million USD | -439.73% |
| 2010 | 112.58 Million USD | -17.12% |
| 2009 | 135.83 Million USD | 56.71% |
| 2008 | 86.68 Million USD | 33.13% |
| 2007 | 65.11 Million USD | 70.21% |
| 2006 | 38.25 Million USD | 27.08% |
| 2005 | 30.1 Million USD | 46.81% |
| 2004 | 20.5 Million USD | 143.89% |
| 2003 | 8.4 Million USD | 1017.95% |
| 2002 | 752 Thousand USD | -86.04% |
| 2001 | 5.38 Million USD | -15.45% |
| 2000 | 6.37 Million USD | 390.0% |
| 1999 | 1.3 Million USD | 105.23% |
| 1998 | -24.87 Million USD | -1983.0% |
| 1997 | -1.19 Million USD | -6617.11% |
| 1996 | 18.32 Thousand USD | -97.96% |
| 1995 | 900 Thousand USD | 0.0% |
| 1994 | - USD | 100.0% |
| 1993 | -100 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 14.4 Million USD | -63.43% |
| 2024 Q2 | 32.3 Million USD | 124.31% |
| 2023 FY | -9.74 Million USD | -108.22% |
| 2023 Q4 | 39.37 Million USD | 51.68% |
| 2023 Q1 | 25.24 Million USD | -20.4% |
| 2023 Q2 | -80.27 Million USD | -417.97% |
| 2023 Q3 | 25.96 Million USD | 132.34% |
| 2022 Q4 | 31.71 Million USD | 23.69% |
| 2022 Q2 | 29.57 Million USD | -6.61% |
| 2022 Q1 | 31.67 Million USD | -6.98% |
| 2022 Q3 | 25.64 Million USD | -13.31% |
| 2022 FY | 118.6 Million USD | -43.27% |
| 2021 Q4 | 34.04 Million USD | -24.35% |
| 2021 FY | 209.07 Million USD | 13.87% |
| 2021 Q1 | 49.87 Million USD | 10.45% |
| 2021 Q2 | 80.14 Million USD | 60.72% |
| 2021 Q3 | 45 Million USD | -43.85% |
| 2020 Q3 | 71.98 Million USD | 107.59% |
| 2020 Q4 | 45.15 Million USD | -37.27% |
| 2020 Q2 | 34.67 Million USD | 9.03% |
| 2020 Q1 | 31.8 Million USD | 15.0% |
| 2020 FY | 183.6 Million USD | 44.76% |
| 2019 Q1 | 31.3 Million USD | 13.99% |
| 2019 FY | 126.83 Million USD | 6.27% |
| 2019 Q2 | 33.74 Million USD | 7.79% |
| 2019 Q3 | 34.13 Million USD | 1.16% |
| 2019 Q4 | 27.65 Million USD | -18.98% |
| 2018 Q1 | 27.15 Million USD | 805.8% |
| 2018 Q2 | 33.34 Million USD | 22.79% |
| 2018 Q4 | 27.46 Million USD | -12.48% |
| 2018 Q3 | 31.37 Million USD | -5.91% |
| 2018 FY | 119.34 Million USD | 293.87% |
| 2017 Q4 | -3.84 Million USD | -126.43% |
| 2017 FY | 30.3 Million USD | -18.68% |
| 2017 Q1 | 15.13 Million USD | 69.68% |
| 2017 Q2 | 4.46 Million USD | -70.52% |
| 2017 Q3 | 14.55 Million USD | 226.34% |
| 2016 Q2 | 10.69 Million USD | 72.16% |
| 2016 Q4 | 8.91 Million USD | -22.02% |
| 2016 Q1 | 6.21 Million USD | -51.88% |
| 2016 Q3 | 11.43 Million USD | 6.91% |
| 2016 FY | 37.26 Million USD | 1333.4% |
| 2015 Q3 | 8.44 Million USD | -20.65% |
| 2015 Q4 | 12.91 Million USD | 52.97% |
| 2015 Q2 | 10.63 Million USD | 130.38% |
| 2015 Q1 | -35 Million USD | -483.24% |
| 2015 FY | -3.02 Million USD | -123.65% |
| 2014 Q4 | 9.13 Million USD | 8.25% |
| 2014 Q2 | 7.61 Million USD | 161.36% |
| 2014 FY | 12.77 Million USD | 113.28% |
| 2014 Q3 | 8.43 Million USD | 10.76% |
| 2014 Q1 | -12.41 Million USD | -28.95% |
| 2013 Q2 | 1.84 Million USD | -31.28% |
| 2013 FY | -96.17 Million USD | -15.06% |
| 2013 Q4 | -9.62 Million USD | 89.43% |
| 2013 Q3 | -91.06 Million USD | -5046.71% |
| 2013 Q1 | 2.67 Million USD | 102.51% |
| 2012 FY | -83.58 Million USD | 78.14% |
| 2012 Q1 | 5.42 Million USD | 25.64% |
| 2012 Q2 | 7.88 Million USD | 45.42% |
| 2012 Q3 | 9.92 Million USD | 25.88% |
| 2012 Q4 | -106.81 Million USD | -1176.52% |
| 2011 Q3 | -423.72 Million USD | -2056.6% |
| 2011 FY | -382.46 Million USD | -439.73% |
| 2011 Q1 | 15.28 Million USD | -30.82% |
| 2011 Q4 | 4.31 Million USD | 101.02% |
| 2011 Q2 | 21.65 Million USD | 41.65% |
| 2010 Q1 | 36.64 Million USD | -3.03% |
| 2010 Q2 | 32.2 Million USD | -12.13% |
| 2010 Q3 | 21.63 Million USD | -32.82% |
| 2010 Q4 | 22.09 Million USD | 2.14% |
| 2010 FY | 112.58 Million USD | -17.12% |
| 2009 FY | 135.83 Million USD | 56.71% |
| 2009 Q4 | 37.79 Million USD | 5.16% |
| 2009 Q3 | 35.94 Million USD | 2.44% |
| 2009 Q2 | 35.08 Million USD | 29.83% |
| 2009 Q1 | 27.02 Million USD | 2.59% |
| 2008 Q3 | 23.49 Million USD | 15.25% |
| 2008 Q4 | 26.34 Million USD | 12.12% |
| 2008 FY | 86.68 Million USD | 33.13% |
| 2008 Q2 | 20.38 Million USD | 23.81% |
| 2008 Q1 | 16.46 Million USD | -1.5% |
| 2007 Q1 | 13.26 Million USD | 16.78% |
| 2007 FY | 65.11 Million USD | 70.21% |
| 2007 Q4 | 16.71 Million USD | -17.32% |
| 2007 Q3 | 20.21 Million USD | 35.52% |
| 2007 Q2 | 14.91 Million USD | 12.45% |
| 2006 Q4 | 11.35 Million USD | 7.58% |
| 2006 Q3 | 10.55 Million USD | 16.64% |
| 2006 Q2 | 9.05 Million USD | 24.29% |
| 2006 Q1 | 7.28 Million USD | -0.25% |
| 2006 FY | 38.25 Million USD | 27.08% |
| 2005 Q2 | 7.93 Million USD | 11.53% |
| 2005 FY | 30.1 Million USD | 46.81% |
| 2005 Q4 | 7.3 Million USD | -5.9% |
| 2005 Q3 | 7.76 Million USD | -2.14% |
| 2005 Q1 | 7.11 Million USD | 15.87% |
| 2004 Q2 | 4.96 Million USD | 17.53% |
| 2004 Q4 | 6.13 Million USD | 18.32% |
| 2004 Q3 | 5.18 Million USD | 4.54% |
| 2004 Q1 | 4.22 Million USD | 25.51% |
| 2004 FY | 20.5 Million USD | 143.89% |
| 2003 Q3 | 2.38 Million USD | 57.27% |
| 2003 Q2 | 1.51 Million USD | 31.77% |
| 2003 FY | 8.4 Million USD | 1017.95% |
| 2003 Q1 | 1.14 Million USD | 118.75% |
| 2003 Q4 | 3.36 Million USD | 41.24% |
| 2002 Q3 | 1.21 Million USD | -26.57% |
| 2002 Q2 | 1.66 Million USD | -19.65% |
| 2002 FY | 752 Thousand USD | -86.04% |
| 2002 Q4 | -6.12 Million USD | -602.71% |
| 2002 Q1 | 2.06 Million USD | -21.65% |
| 2001 Q3 | 1.97 Million USD | 57.36% |
| 2001 Q4 | 2.63 Million USD | 33.32% |
| 2001 FY | 5.38 Million USD | -15.45% |
| 2001 Q1 | 2.21 Million USD | -77.28% |
| 2001 Q2 | 1.25 Million USD | -43.3% |
| 2000 FY | 6.37 Million USD | 390.0% |
| 2000 Q4 | 9.75 Million USD | 1380.31% |
| 2000 Q1 | -1.29 Million USD | -43.44% |
| 2000 Q3 | -762 Thousand USD | 42.88% |
| 2000 Q2 | -1.33 Million USD | -3.33% |
| 1999 Q3 | 6.2 Million USD | 513.33% |
| 1999 FY | 1.3 Million USD | 105.23% |
| 1999 Q4 | -900 Thousand USD | -114.52% |
| 1999 Q2 | -1.5 Million USD | 39.95% |
| 1999 Q1 | -2.49 Million USD | 84.74% |
| 1998 Q4 | -16.37 Million USD | -309.28% |
| 1998 Q1 | -2.5 Million USD | -19.39% |
| 1998 FY | -24.87 Million USD | -1983.0% |
| 1998 Q2 | -1.9 Million USD | 24.0% |
| 1998 Q3 | -4 Million USD | -110.53% |
| 1997 Q3 | 200 Thousand USD | -50.0% |
| 1997 FY | -1.19 Million USD | -6617.11% |
| 1997 Q4 | -2.09 Million USD | -1147.0% |
| 1997 Q1 | 300 Thousand USD | 162.28% |
| 1997 Q2 | 400 Thousand USD | 33.33% |
| 1996 Q2 | 300 Thousand USD | 50.0% |
| 1996 Q3 | 100 Thousand USD | -66.67% |
| 1996 Q4 | -481.67 Thousand USD | -581.68% |
| 1996 FY | 18.32 Thousand USD | -97.96% |
| 1996 Q1 | 200 Thousand USD | 100.0% |
| 1995 Q2 | 200 Thousand USD | 100.0% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1995 FY | 900 Thousand USD | 0.0% |
| 1995 Q4 | 100 Thousand USD | -66.67% |
| 1995 Q3 | 300 Thousand USD | 50.0% |
| 1994 FY | - USD | 100.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q1 | - USD | 100.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 FY | -100 Thousand USD | 0.0% |
| 1993 Q3 | -100 Thousand USD | -200.0% |
| 1993 Q2 | 100 Thousand USD | 0.0% |
| 1993 Q1 | 100 Thousand USD | 0.0% |
| 1993 Q4 | -200 Thousand USD | -100.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 55.015% |
| Addus HomeCare Corporation | 62.51 Million USD | 115.591% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -117.616% |
| American Oncology Network, Inc. | -5.54 Million USD | -75.875% |
| Astrana Health, Inc. | 60.71 Million USD | 116.053% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 92.754% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 393.938% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -2.367% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 113.42% |
| COMPASS Pathways plc | -118.46 Million USD | 91.772% |
| DocGo Inc. | 6.85 Million USD | 242.117% |
| The Ensign Group, Inc. | 209.39 Million USD | 104.655% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 125.392% |
| InnovAge Holding Corp. | -21.33 Million USD | 54.321% |
| Assure Holdings Corp. | -26.07 Million USD | 62.624% |
| The Joint Corp. | -9.75 Million USD | 0.053% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 94.767% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 37.53% |
| ModivCare Inc. | -204.46 Million USD | 95.233% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 7586.578% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | 26.24% |
| Option Care Health, Inc. | 267.09 Million USD | 103.649% |
| P3 Health Partners Inc. | -57.77 Million USD | 83.129% |
| P3 Health Partners Inc. | -57.77 Million USD | 83.129% |
| The Pennant Group, Inc. | 13.37 Million USD | 172.853% |
| Surgery Partners, Inc. | -11.9 Million USD | 18.092% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -231.718% |
| Talkspace, Inc. | -19.18 Million USD | 49.187% |
| Talkspace, Inc. | -19.18 Million USD | 49.187% |
| The Oncology Institute, Inc. | -83.06 Million USD | 88.266% |
| The Oncology Institute, Inc. | -83.06 Million USD | 88.266% |